Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Kolben

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Breast Care (Basel, Switzerland)|May 4, 2012
Use of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer at German Breast Cancer Centers and University Hospitals - Results of an Enquiry (Adjuvant Endocrine Therapy Enquiry)Thomas Kolben, Susanne Engelmann, Susanne Maurer, et al.
Trials|May 24, 2015
Comparison of two surgical methods for the treatment of CIN: classical LLETZ (large-loop excision of the transformation zone) versus isolated resection of the colposcopic apparent lesion - study protocol for a randomized controlled trialTheresa M Schwarz, Thomas Kolben, Julia Gallwas, et al.
Geburtshilfe Und Frauenheilkunde|November 10, 2025
Vaginal Breech Birth: Learnings from 21 Years of Retrospective Data AnalysisJohanna Buechel, Jennifer Obermayer, Linda Hertlein, et al.
Breast Care (Basel, Switzerland)|February 22, 2024
Use of the Gene Expression Test Prosigna<sup>®</sup> in Premenopausal Patients with HR+, HER2- Early Breast Cancer: Correlation of the Results with the Proliferation Marker Ki-67Cordula Ziegler, Karl Sotlar, Daniel Maria Hofmann, et al.
Deutsches Arzteblatt International|July 7, 2022
SARS-CoV-2 Infection During PregnancyUlrich Pecks, Nadine Mand, Thomas Kolben, et al.
BMC Women'S Health|April 28, 2025
Can the CANKADO online application improve quality of life monitoring via the endometriosis health profile-30 in endometriosis patients: A randomized cohort study on acceptance, usability, and correlations with demographics and media usageLucia Ehmann, Maresa Jäger, Lina Folger, et al.
Therapeutic Advances in Drug Safety|August 28, 2023
Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customersFlorian Schindler, Timo Schinkoethe, Sven Mahner, et al.
International Journal of Molecular Sciences|July 26, 2020
Early Life Oxidative Stress and Long-Lasting Cardiovascular Effects on Offspring Conceived by Assisted Reproductive Technologies: A ReviewHuixia Yang, Christina Kuhn, Thomas Kolben, et al.
Breast Care (Basel, Switzerland)|November 23, 2020
Metastatic Breast Cancer: Is There a Differential Therapy Efficacy between Visceral and Non-Visceral Metastatic Breast Cancer?Thomas Kolben, Maximilian Bardenhewer, Theresa M Kolben, et al.
Breast Care (Basel, Switzerland)|January 26, 2026
Comparison of Prosigna® Assay and Urokinase Plasminogen Activator/Plasminogen Activator Inhibitor-1 Results in Early-Stage Breast Cancer PatientsLaura Rickerl, Harald Bartsch, Nadia Harbeck, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Breast Care (Basel, Switzerland)|May 4, 2012
Use of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer at German Breast Cancer Centers and University Hospitals - Results of an Enquiry (Adjuvant Endocrine Therapy Enquiry)Thomas Kolben, Susanne Engelmann, Susanne Maurer, et al.
Trials|May 24, 2015
Comparison of two surgical methods for the treatment of CIN: classical LLETZ (large-loop excision of the transformation zone) versus isolated resection of the colposcopic apparent lesion - study protocol for a randomized controlled trialTheresa M Schwarz, Thomas Kolben, Julia Gallwas, et al.
Geburtshilfe Und Frauenheilkunde|November 10, 2025
Vaginal Breech Birth: Learnings from 21 Years of Retrospective Data AnalysisJohanna Buechel, Jennifer Obermayer, Linda Hertlein, et al.
Breast Care (Basel, Switzerland)|February 22, 2024
Use of the Gene Expression Test Prosigna<sup>®</sup> in Premenopausal Patients with HR+, HER2- Early Breast Cancer: Correlation of the Results with the Proliferation Marker Ki-67Cordula Ziegler, Karl Sotlar, Daniel Maria Hofmann, et al.
Deutsches Arzteblatt International|July 7, 2022
SARS-CoV-2 Infection During PregnancyUlrich Pecks, Nadine Mand, Thomas Kolben, et al.
BMC Women'S Health|April 28, 2025
Can the CANKADO online application improve quality of life monitoring via the endometriosis health profile-30 in endometriosis patients: A randomized cohort study on acceptance, usability, and correlations with demographics and media usageLucia Ehmann, Maresa Jäger, Lina Folger, et al.
Therapeutic Advances in Drug Safety|August 28, 2023
Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customersFlorian Schindler, Timo Schinkoethe, Sven Mahner, et al.
International Journal of Molecular Sciences|July 26, 2020
Early Life Oxidative Stress and Long-Lasting Cardiovascular Effects on Offspring Conceived by Assisted Reproductive Technologies: A ReviewHuixia Yang, Christina Kuhn, Thomas Kolben, et al.
Breast Care (Basel, Switzerland)|November 23, 2020
Metastatic Breast Cancer: Is There a Differential Therapy Efficacy between Visceral and Non-Visceral Metastatic Breast Cancer?Thomas Kolben, Maximilian Bardenhewer, Theresa M Kolben, et al.
Breast Care (Basel, Switzerland)|January 26, 2026
Comparison of Prosigna® Assay and Urokinase Plasminogen Activator/Plasminogen Activator Inhibitor-1 Results in Early-Stage Breast Cancer PatientsLaura Rickerl, Harald Bartsch, Nadia Harbeck, et al.
Pageof 11